The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout

By sjmartinez • March 12, 2024

Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, Lioté F, Gaffo A, FitzGerald J, Terkeltaub R, Sise ME, Januzzi JL, Wexler DJ, Choi HK. The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout. Nat Rev Rheumatol. 2024 Mar 12. doi: 10.1038/s41584-024-01092-x. Epub ahead of print. PMID: 38472344.

Tags: Publications, Rheumatology, Veterans Administration

Metastatic metaplastic triple negative breast cancer response to sacituzumab govitecan and biomarker targetability

Maheswaran S, Dedeoglu AS, Niemierko A, Abelman RO, Jimenez R, Rieur O, Hutchinson J, Vidula N, Spring LM, Ellisen LW, Isakoff SJ, Wander SA, Bardia[...]

A Phase I Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients with Advanced Gastrointestinal Cancers

Fakih M, Doi T, Tolcher A, Hong D, Tie J, Messersmith W, Koyama T, Rosen L, Borlido J, Damore MA, Delioukina M, Cheronis I, Clark[...]

Critical Rheumatic Mitral Stenosis Unmasked During Pregnancy Complicated by Preeclampsia With Severe Features and Managed With Urgent Balloon Mitral Valvuloplasty

Gorsi U, Kim N, Sukhija R, Kumar J, Nabavizadeh P. Critical Rheumatic Mitral Stenosis Unmasked During Pregnancy Complicated by Preeclampsia With Severe Features and Managed[...]